Literature DB >> 21389683

Depletion of plasma gelsolin in patients with tick-borne encephalitis and Lyme neuroborreliosis.

Alina Kułakowska1, Joanna M Zajkowska, Nicholas J Ciccarelli, Barbara Mroczko, Wiesław Drozdowski, Robert Bucki.   

Abstract

BACKGROUND/AIMS: Cell damage during the course of inflammation results in cytoplasmic actin release, which if not eliminated by the extracellular actin scavenger system, composed of gelsolin and vitamin D binding protein, can cause dysfunction of hemostasis and toxicity towards surrounding cells. In this study, we test the hypothesis that an inflammatory reaction induced by central nervous system infections such as tick-borne encephalitis (TBE) or Lyme neuroborreliosis (LNB) will result in plasma gelsolin concentration changes in the blood and cerebrospinal fluid (CSF).
METHODS: Quantitative Western blot was used to determine gelsolin levels in 58 samples, which include: 29 patients without infection (diagnosed with conditions such as idiopathic cephalalgia, idiopathic Bell's facial nerve palsy and ischialgia due to discopathy in which standard CSF diagnostic tests show no abnormalities), 12 patients diagnosed with TBE, and 17 patients diagnosed with LNB sub forma meningitis. RESULTS AND
CONCLUSION: The gelsolin concentration in the blood of patients with TBE (163.2 ± 80.8 μg/ml) and LNB (113.6 ± 56.8 μg/ml) was significantly lower (p < 0.05 and p < 0.001, respectively) compared to the control group (226.3 ± 100.7 μg/ml). Furthermore, there was no statistically significant difference between the CSF gelsolin concentration in patients with TBE (3.9 ± 3.3 μg/ml), LNB (2.9 ± 1.2 μg/ml) and the control group (3.7 ± 3.3 μg/ml). An observed decrease in gelsolin concentration in the blood of TBE and LNB patients supports previous findings indicating the involvement of gelsolin in the pathophysiology of an inflammatory response. Therefore, evaluation of blood gelsolin concentration and administration of recombinant plasma gelsolin might provide a new tool to develop diagnostic and therapeutic strategies for TBE and LNB.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21389683      PMCID: PMC3121545          DOI: 10.1159/000324373

Source DB:  PubMed          Journal:  Neurodegener Dis        ISSN: 1660-2854            Impact factor:   2.977


  31 in total

Review 1.  Mechanisms of disease: the blood-brain barrier.

Authors:  Edward A Neuwelt
Journal:  Neurosurgery       Date:  2004-01       Impact factor: 4.654

2.  Circulating actin-gelsolin complexes following oleic acid-induced lung injury.

Authors:  D B Smith; P A Janmey; S E Lind
Journal:  Am J Pathol       Date:  1988-02       Impact factor: 4.307

3.  Selection of a Borrelia burgdorferi antigenic variant by cultivation in the presence of increasing amounts of homologous immune serum.

Authors:  M Cinco
Journal:  FEMS Microbiol Lett       Date:  1992-04-01       Impact factor: 2.742

4.  Plasma gelsolin modulates cellular response to sphingosine 1-phosphate.

Authors:  Robert Bucki; Alina Kulakowska; Fitzroy J Byfield; Malgorzata Zendzian-Piotrowska; Marcin Baranowski; Michal Marzec; Jessamine P Winer; Nicholas J Ciccarelli; Jan Górski; Wieslaw Drozdowski; Robert Bittman; Paul A Janmey
Journal:  Am J Physiol Cell Physiol       Date:  2010-09-01       Impact factor: 4.249

5.  Relationship of admission plasma gelsolin levels to clinical outcomes in patients after major trauma.

Authors:  K C Mounzer; M Moncure; Y R Smith; M J Dinubile
Journal:  Am J Respir Crit Care Med       Date:  1999-11       Impact factor: 21.405

6.  Depression of gelsolin levels and detection of gelsolin-actin complexes in plasma of patients with acute lung injury.

Authors:  S E Lind; D B Smith; P A Janmey; T P Stossel
Journal:  Am Rev Respir Dis       Date:  1988-08

7.  Recombinant plasma gelsolin infusion attenuates burn-induced pulmonary microvascular dysfunction.

Authors:  Patricia A Rothenbach; Benny Dahl; Jason J Schwartz; Grant E O'Keefe; Masaya Yamamoto; William M Lee; Jureta W Horton; Helen L Yin; Richard H Turnage
Journal:  J Appl Physiol (1985)       Date:  2003-05-02

8.  Changes in immune parameters and their correction in human cases of tick-borne encephalitis.

Authors:  A V Atrasheuskaya; T M Fredeking; G M Ignatyev
Journal:  Clin Exp Immunol       Date:  2003-01       Impact factor: 4.330

9.  Muscle is the major source of plasma gelsolin.

Authors:  D J Kwiatkowski; R Mehl; S Izumo; B Nadal-Ginard; H L Yin
Journal:  J Biol Chem       Date:  1988-06-15       Impact factor: 5.157

10.  Prognostic implications of declining plasma gelsolin levels after allogeneic stem cell transplantation.

Authors:  Mark J DiNubile; Thomas P Stossel; Olof C Ljunghusen; James L M Ferrara; Joseph H Antin
Journal:  Blood       Date:  2002-08-01       Impact factor: 22.113

View more
  6 in total

1.  Plasma gelsolin accumulates in macrophage nodules in brains of simian immunodeficiency virus infected rhesus macaques.

Authors:  T Jagadish; G Pottiez; H S Fox; P Ciborowski
Journal:  J Neurovirol       Date:  2012-03-09       Impact factor: 2.643

2.  Increased levels of sphingosine-1-phosphate in cerebrospinal fluid of patients diagnosed with tick-borne encephalitis.

Authors:  Alina Kułakowska; Fitzroy J Byfield; Małgorzata Zendzian-Piotrowska; Joanna M Zajkowska; Wiesław Drozdowski; Barbara Mroczko; Paul A Janmey; Robert Bucki
Journal:  J Neuroinflammation       Date:  2014-11-25       Impact factor: 8.322

3.  A database of human genes and a gene network involved in response to tick-borne encephalitis virus infection.

Authors:  Elena V Ignatieva; Alexander V Igoshin; Nikolay S Yudin
Journal:  BMC Evol Biol       Date:  2017-12-28       Impact factor: 3.260

4.  Pre-operative Circulating Plasma Gelsolin Predicts Residual Disease and Detects Early Stage Ovarian Cancer.

Authors:  Meshach Asare-Werehene; Laudine Communal; Euridice Carmona; Tien Le; Diane Provencher; Anne-Marie Mes-Masson; Benjamin K Tsang
Journal:  Sci Rep       Date:  2019-09-26       Impact factor: 4.379

5.  Change in blood gelsolin concentration in response to physical exercise.

Authors:  C-C Yu; M Zendzian-Piotrowska; M Charmas; B Długołęcka; M Baranowski; J Górski; R Bucki
Journal:  Biol Sport       Date:  2013-07-22       Impact factor: 2.806

Review 6.  Plasma Gelsolin: Indicator of Inflammation and Its Potential as a Diagnostic Tool and Therapeutic Target.

Authors:  Ewelina Piktel; Ilya Levental; Bonita Durnaś; Paul A Janmey; Robert Bucki
Journal:  Int J Mol Sci       Date:  2018-08-25       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.